Aicaigou LogoAicaigou LogoB2B WikiIndustrial Encyclopedia

Tyrosinemia

Updated: 2026-07-15

Overview

Tyrosinemia is a group of autosomal recessive metabolic disorders caused by defects in tyrosine metabolism. The condition results in abnormal accumulation of tyrosine and its metabolites, leading to multisystem toxicity. Type I tyrosinemia (the most severe form) involves fumarylacetoacetate hydrolase deficiency, while Types II and III involve tyrosine aminotransferase and 4-hydroxyphenylpyruvate dioxygenase deficiencies respectively. These disorders present in infancy or childhood with symptoms ranging from liver failure and renal tubular dysfunction to neurological crises and developmental delays. Newborn screening programs in many countries now routinely test for tyrosinemia to enable early intervention. The biochemical hallmark is elevated tyrosine levels in blood and urine, detectable through specialized laboratory testing.

Physical and Chemical Properties

4-丁基间苯二酚 优级品 酪氨酸酶抑制剂 减少黑色素生成广州普逸丰生物科技有限公司

Tyrosine (4-hydroxyphenylalanine) is a non-essential amino acid with a polar side chain containing a hydroxyl group. Its molecular structure includes both aromatic and hydrophilic components, contributing to its amphipathic nature. In tyrosinemia patients, tyrosine's normal catabolic pathway is disrupted, leading to accumulation of intermediates like succinylacetone - a highly reactive compound that forms covalent bonds with cellular proteins. The solubility characteristics of tyrosine derivatives influence their pathological effects. While tyrosine itself is water-soluble, some metabolic byproducts become concentrated in lipid-rich tissues. The melting point of pure tyrosine crystals (343°C) indicates strong intermolecular forces, which become relevant when considering pharmaceutical formulations for treatment.

商家经验真实案例 · 安全可信
六月份柑橘管理
本文从肥水调控、病虫害防治和果实管理三方面,详解六月柑橘园的关键操作。梅雨季需重点防涝控旺,同时把握幼果膨大期营养供给,科学应对高温高湿环境下的炭疽病、红蜘蛛等威胁,为丰收打下基础。

Main Applications

In clinical practice, tyrosine and its analogs serve multiple purposes. Nitisinone (NTBC), a potent inhibitor of 4-hydroxyphenylpyruvate dioxygenase, has become the first-line treatment for tyrosinemia type I by blocking the formation of toxic metabolites. This pharmaceutical application represents the most significant commercial use of tyrosine pathway biochemistry. Diagnostically, tyrosine and its derivatives are measured in blood spots, urine, and amniotic fluid for screening and monitoring. Research-grade tyrosine isotopes are used in metabolic studies, while modified tyrosine compounds find applications in developing enzyme replacement therapies. The amino acid also serves as a raw material for synthesizing specialized nutritional products for patients with restricted diets.

Safety and Storage

L-酪氨酸 食品级营养强化剂增补剂 白色粉末状 支持拿样 现货现发山东鼎醇生物科技有限公司

Tyrosine-related compounds require careful handling due to their biochemical activity. Pharmaceutical-grade materials must be stored in temperature-controlled environments (typically 2-8°C) with humidity below 60% to prevent degradation. Laboratory reagents should be kept in airtight containers with desiccants to maintain stability. For patient safety, dietary tyrosine restriction must be carefully monitored to avoid both toxicity and deficiency. Medical professionals should be aware that excessive protein restriction can lead to growth impairment, requiring precise balancing with essential amino acid supplements. Emergency protocols should be established for acute metabolic decompensation episodes in affected patients.

商家经验真实案例 · 安全可信
智能可可粉零售
本文探讨智能可可粉零售的现状与未来,分析其技术应用、消费者体验优化及市场潜力,为行业从业者提供前瞻性视角。

B2B Procurement Guide

When sourcing tyrosine-related products for medical use, buyers should verify suppliers' Good Manufacturing Practice (GMP) certification and analytical testing capabilities. Key procurement considerations include batch-to-batch consistency, endotoxin levels for injectable formulations, and documentation of heavy metal testing. For research applications, purity standards (typically ≥98% for biochemical studies) and isotopic labeling specifications must be confirmed. Bulk pharmaceutical buyers should establish long-term supply agreements with manufacturers capable of providing regulatory support documentation. Consider regional variations in approval status for tyrosine metabolism-modifying drugs when sourcing for international markets.

Related Manufacturers